In vivo transplantation of autogenous marrow-derived cells following rapid intraoperative magnetic separation based on hyaluronan to augment bone regeneration

Tissue Engineering - Part A

Volumn 19, Issue 1-2, 2013, Pages 125-134

  Caralla, Tonya ^a,b   Joshi, Powrnima ^a   Fleury, Sean ^a   Luangphakdy, Viviane ^a   Shinohara, Kentaro ^a   Pan, Hui ^a   Boehm, Cynthia ^a   Vasanji, Amit ^c   Hefferan, Theresa E ^d   Walker, Esteban ^a   Yaszemski, Michael ^d   Hascall, Vincent ^a   Zborowski, Maciej ^a   Muschler, George F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Case Western Reserve University   (United States)

^c ImageIQ   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DEFECT MODELS; BONE FORMATION; BONE MARROW; BONE REGENERATION; BONE VOLUME; CONNECTIVE TISSUES; HYALURONAN; IN-VIVO; INTRA-OPERATIVE; MICRO COMPUTED TOMOGRAPHY (MICRO-CT); MICRO CT; OSTEOCONDUCTIVE; POSITIVE SELECTION; RED BLOOD CELL; SURFACE MARKERS;

CELLS; COLLAGEN; COMPUTERIZED TOMOGRAPHY; CYTOLOGY; GRAFTING (CHEMICAL); GRAFTS; LOADING; MAGNETIC SEPARATION; MUSCULOSKELETAL SYSTEM; SCAFFOLDS (BIOLOGY);

BONE;

HYALURONIC ACID;

ANIMAL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BONE REGENERATION; CELL CULTURE; CELL SEPARATION; CYTOLOGY; DOG; FEMUR FRACTURE; IMMUNOMAGNETIC SEPARATION; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BONE REGENERATION; CELL SEPARATION; CELLS, CULTURED; DOGS; FEMORAL FRACTURES; HYALURONIC ACID; IMMUNOMAGNETIC SEPARATION; TREATMENT OUTCOME;

EID: 84871318040     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0622     Document Type: Article

References (31)

1. Bishop, G.B., and Einhorn, T.A. Current and future clinical applications of bone morphogenic proteins in orthopaedic trauma surgery. Int Orthop 31, 721, 2007.
2. Bucholz, R., Heckman, J., and Court-Brown, C. (Eds.). Rockwood and Green's Fractures in Adults, 6th edition. Philadelphia, PA: Lippincott, Williams, & Wilkins 2006.
3. Muschler, G., Nakamoto, C., and Griffith, L. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg 86A, 1541, 2004.
4. Muschler, G., Boehm, C., and Easley, K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: The influence of aspiration volume. J Bone Joint Surg Am 79, 1699, 1997.
5. Majors, A.K., Boehm, C.A., Nitto, H., Midura, R.J., and Muschler, G.F. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15, 546, 1997.
6. Muschler, G., and Midura, R. Connective tissue progenitors: Practical concepts for clinical applications. Clin Orthop 395, 66, 2002.
7. Shinohara, K., Greenfield, S., Pan, H., Vasanji, A., Kumagai, K., Midura, R.J., Kiedrowski, M., Penn, M.S., and Muschler, G.F. Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res 29, 1064, 2011.
8. Boban, I., Barisic-Dujmovic, T., and Clark, S. Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis 48, 171, 2010.
9. Hernigou, P., Poignard, A., Beaujean, F., and Rouard, H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87, 1430, 2005.
10. Muschler, G.F., Nitto, H., Matsukura, Y., Boehm, C., Valdevit, A., Kambic, H.E., Davros, W.J., Powell, K., and Easley, K. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 407, 102, 2003.
11. Muschler, G.F., Matsukura, Y., Nitto, H., Boehm, C.A., Valdevit, A.D., Kambic, H.E., Davros, W.J., Easley, K.A., and Powell, K. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop 432, 242, 2005.
12. Tiedeman, J.J., Connolly, J.F., Strates, B.S., and Lippiello L. Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. Clin Orthop 268, 294, 1991.
13. Connolly, J.F. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop 313, 8, 1995.
14. Hernigou, P., Poignard, A., Manicom, O., Mathieu, G., and Rouard, H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 87, 896, 2005.
15. Simmons, P., and Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody. Blood 78, 55, 1991.
16. Quirici, N., Soligo, D., Bossolasco, P., et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30, 783, 2002.
17. Deschaseaux, F., and Chambord, P. Human marrow stromal cell precursors are alpha 1 integrin subunit-positive. J Cell Physiol 184, 319, 2000.
18. Crisan, M., Yap, S., Casteilla, L., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
19. Boriet, N., Rapatel, C., Boisgard, S., et al. CD34 + CDw90(Thy-1) + subset collocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony forming unit megakaryocytes and longterm culture-initiating cells. Exp Hematol 31, 1275, 2003.
20. Caralla, T., Boehm, C., Hascall, V., and Muschler, G. Hyaluronan as a novel marker for rapid selection of connective tissue progenitors. Ann Biomed Eng 2012 [Epub ahead of print]; DOI: 10.1007/s10439-012-0608-2.
21. Wang, A., and Hascall, V. Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte binding. J Biol Chem 279, 10279, 2004.
22. Takigami, H., Kumagai, K., Latson, L., Daisuke Togawa, D., Bauer, T., Powell, K., Butler, R.S., and Muschler, G.F. Bone formation following OP-1 implantation is improved by addition of autogenous bone marrow cells in a canine femur defect model. J Orthop Res 25, 1333, 2007.
23. Muschler, G.F., Raut, V.P., Patterson, T.E., Wenke, J.C., and Hollinger, J.O. The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng Part B Rev 16, 123, 2010.
24. Raut, V.P., Patterson, T.E., Wenke, J.C., Hollinger, J.O., and Muschler, G.F. Assessment of biomaterials: Standardized in vivo testing. In: Guelcher, S.A., and Hollinger, J.O., eds. An Introduction to Biomaterials. Boca Raton, FL: CRC Press, 2010.
25. Villarruel, S., Boehm, C., Pennington, M., et al. The effect of oxygen tension on the in vitro assay of human osteoblastic connective tissue progenitor cells J Orthop Res 26, 1390, 2008.
26. Powell, K., Nakamoto, C., Villarruel, S., et al. Quantitative image analysis of connective tissue progenitors. Anal Quant Cytol Histol 29, 112, 2007.
27. Muir, J.M., Hirsh, J., Weitz, J.I., et al. A histomorphometric comparison of the effects of heparin and low-molecular weight heparin on cancellous bone in rats. Blood 89, 3236 1997.
28. Nishiyama, M., Itoh, F., and Ujiie, A. Low-molecular-weight heparin (dalteparin) demonstrated a weaker effect on rat bone metabolism compared with heparin. Jpn J Pharmacol 74, 59, 1997.
29. Kock, H.J., Werther, S., Uhlenkott, H., and Taeger, G. Influence of unfractionated and low-molecular-weight heparin on bone healing: An animal model. Unfallchirurg 105, 791, 2002.
30. Erli, H., Melchert, M., and Rueger, M. The effect of lowdosed unfractioned and low-molecular-weight heparins on bone healing in vivo. Int J Orthop Surg 3, 2006. Available at www.ispub.com/ostia/index.php?xmlFilePath= journals/ijos/vol3n2/heparin.xml. DOI: 10.5580/1f1d.
31. Muschler, G.F., Huber, B., Ullman, T., Barth, R., Easley, K., Otis, J.O., and Lane, J.M. Evaluation of bone-grafting materials in a new canine segmental spinal fusion model. J Orthop Res 11, 514, 1993.